Loading…
Transcode Therapeutics Inc Is A Clinical-Stage Biotechnology Company Engaged In The Development Of Rna-Based Therapeutics And Immuno-Oncology Treatments For Cancer. The Company'S Lead Candidate, Ttx-Mc138, Targets Microrna-10b And Has Completed A Phase 1a Clinical Trial, While It Is Also Advancing Additional Product Candidates, Including A Cancer Vaccine And An Oncolytic Immunotherapy Platform.